{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:38:45Z","timestamp":1760042325880},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,1,26]],"date-time":"2007-01-26T00:00:00Z","timestamp":1169769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2007,9,14]]},"DOI":"10.1007\/s10067-006-0487-8","type":"journal-article","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T10:01:24Z","timestamp":1169719284000},"page":"1737-1740","source":"Crossref","is-referenced-by-count":15,"title":["Severe limb necrosis: primary thrombotic microangiopathy or \u201cseronegative\u201d catastrophic antiphospholipid syndrome? A diagnostic dilemma"],"prefix":"10.1007","volume":"26","author":[{"given":"I.","family":"Lazurova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Macejova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Tomkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Remenar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Boor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lazur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Roland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Rovensky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. A.","family":"Asherson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,1,26]]},"reference":[{"key":"487_CR1","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.2.4790.897","volume":"2","author":"W Symmers","year":"1952","unstructured":"Symmers W (1952) Thrombotic microangiopathic haemolytic anemia (thrombotic microangiopathy). BMJ 2:897\u2013903","journal-title":"BMJ"},{"issue":"6","key":"487_CR2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2003.007245","volume":"63","author":"G Espinosa","year":"2004","unstructured":"Espinosa G, Bucciarelli S, Cervera R et al (2004) Thrombotic microangiopathic hemolytic anemia and antiphospholipid antibodies. Ann Rheum Dis 63(6):730\u2013736","journal-title":"Ann Rheum Dis"},{"key":"487_CR3","first-page":"508","volume":"19","author":"RA Asherson","year":"1992","unstructured":"Asherson RA (1992) The catastrophic antiphospholipid syndrome. J Rheumatol 19:508\u2013512","journal-title":"J Rheumatol"},{"key":"487_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00005792-199303000-00005","volume":"72","author":"R Cervera","year":"1993","unstructured":"Cervera R, Khamashta MA, Font J et al (1993) Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1,000 patients. The European working party on systemic lupus erythematosus. Medicine (Baltimore) 72:113\u2013124","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"487_CR5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2006-939763","volume":"32","author":"M Galbusera","year":"2006","unstructured":"Galbusera M, Noris M, Remuzzi G (2006) Thrombotic thrombocytopenic purpura\u2014then and now. Semin Thromb Hemost 32(2):81\u201389","journal-title":"Semin Thromb Hemost"},{"key":"487_CR6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.ki.5001535","volume":"70","author":"HM Tsai","year":"2006","unstructured":"Tsai HM (2006) The molecular biology of thrombotic microangiopathy. Kidney Int 70:16\u201323, DOI 10.1038\/sj.ki 5001535","journal-title":"Kidney Int"},{"key":"487_CR7","first-page":"2007","volume":"155","author":"AMS McInyk","year":"1995","unstructured":"McInyk AMS et al (1995) Adult hemolytic\u2013anemic syndrome: a review of 37 cases. Arch Intern Med 155:2007","journal-title":"Arch Intern Med"},{"issue":"4","key":"487_CR8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.5414\/CNP64305","volume":"64","author":"K Fujisaki","year":"2005","unstructured":"Fujisaki K, Masutani K, Yoshimitsu T et al (2005) Thrombotic thrombocytopenic purpura associated with polyarteritis nodosa. Clin Nephrol 64(4):305\u2013310","journal-title":"Clin Nephrol"},{"key":"487_CR9","first-page":"271","volume-title":"Disorders of hemostasis and thrombosis. A clinical guide","author":"SH Goodnight","year":"2001","unstructured":"Goodnight SH, Hathaway WE (2001) Disorders of hemostasis and thrombosis. A clinical guide, 2nd edn. McGraw Hill, New York, pp 271\u2013279","edition":"2"},{"key":"487_CR10","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood.V93.4.1264","volume":"93","author":"CT Dang","year":"1999","unstructured":"Dang CT, Magid MS, Weksler B, Chadburn A, Laurence J (1999) Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura. Blood 93:1264\u20131270","journal-title":"Blood"},{"key":"487_CR11","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood.V89.4.1224","volume":"89","author":"D Mitra","year":"1997","unstructured":"Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J (1997) Thrombotic thrombocytopenic purpura and sporadic hemolytic uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 89:1224\u20131234","journal-title":"Blood"},{"issue":"5","key":"487_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2141.2006.06096.x","volume":"133","author":"DJ Bowen","year":"2006","unstructured":"Bowen DJ, Collins PW (2006) Insights into von Willebrand factor proteolysis: clinical implications. Br J Haematol 133(5):457\u2013467","journal-title":"Br J Haematol"},{"key":"487_CR13","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1309\/RLNMJ01WBJRNLH03","volume":"125","author":"HM Tsai","year":"2006","unstructured":"Tsai HM, Raoufi M, Zhou W et al (2006) ADAMTS 13 -binding IgG are present in patients with thrombotic thrombocytopenic purpura. Am J Clin Pathol 125:592\u2013597","journal-title":"Am J Clin Pathol"},{"key":"487_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.transci.2005.06.003","volume":"34","author":"MJ Morrin","year":"2006","unstructured":"Morrin MJ, Jones FG, McConville J et al (2006) Thrombotic thrombocytopenic purpura secondary to Streptococcus. Transfus Apheresis Sci 34:153\u2013155","journal-title":"Transfus Apheresis Sci"},{"key":"487_CR15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000044936","volume":"78","author":"LG Ardiles","year":"1998","unstructured":"Ardiles LG, Olavarria F, Elgueta M, Moya P, Mezzano S (1998) Anticardiolipin antibodies in classic pediatric hemolytic\u2013uremic syndrome: a possible pathogenic role. Nephron 78:278\u2013283","journal-title":"Nephron"},{"key":"487_CR16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0049-3848(00)00312-1","volume":"100","author":"GF Tempelhoff von","year":"2000","unstructured":"von Tempelhoff GF, Heilmann L, Spanuth E, Kunzmann E, Hommel G (2000) Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP syndrome. Thromb Res 100:363\u2013365","journal-title":"Thromb Res"},{"key":"487_CR17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/ard.2003.006163","volume":"62","author":"MA Khamashta","year":"2003","unstructured":"Khamashta MA, Hughes GRV (2003) Seronegative APS. Ann Rheum Dis 62:1127","journal-title":"Ann Rheum Dis"},{"key":"487_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/17460816.1.1.1","volume":"1","author":"RA Asherson","year":"2006","unstructured":"Asherson RA, Cervera R, Merrill JT (2006) Thrombotic microangiopathic antiphospholipid syndromes: a continuum of conditions? Future Rheumatol 1:1\u201310","journal-title":"Future Rheumatol"},{"key":"487_CR19","first-page":"81","volume":"2","author":"JT Merrill","year":"2006","unstructured":"Merrill JT, Asherson RA (2006) Catastrophic antiphospholipid syndrome nature clinical practice. Rheumatology 2:81\u201389","journal-title":"Rheumatology"},{"issue":"10","key":"487_CR20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.imbio.2005.10.002","volume":"210","author":"RA Asherson","year":"2005","unstructured":"Asherson RA (2005) Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson\u2019s ) syndrome. Immunobiology 210(10):727\u2013733","journal-title":"Immunobiology"},{"key":"487_CR21","first-page":"OC35","volume":"15","author":"GA McCarty","year":"2000","unstructured":"McCarty GA (2000) Seronegative APS (SNAPS) in 53 patients. Seroconversion rate at 3.5\u00a0years. J Autoimmun 15 OC35, A13","journal-title":"J Autoimmun"},{"issue":"4","key":"487_CR22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1423-0410.2006.00747.x","volume":"90","author":"S Fontana","year":"2006","unstructured":"Fontana S, Kremer Hovinga JA, Lammle B, Mansouri Taleghani B (2006) Treatment of thrombotic thrombocytopenic purpura. Vox Sang 90(4):245\u2013254","journal-title":"Vox Sang"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0487-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-006-0487-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-006-0487-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T21:59:39Z","timestamp":1587333579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-006-0487-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,26]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,9,14]]}},"alternative-id":["487"],"URL":"https:\/\/doi.org\/10.1007\/s10067-006-0487-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,26]]}}}